Credit Suisse Raises 2015 TAVI Estimates for Edwards Lifesciences Corp.

By: via Benzinga
In a report published Tuesday, Credit Suisse analyst Bruce Nudell reiterated an Outperform rating and $150.00 price target on Edwards ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.